ALUMIS INC.

ALMS · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $3.1B · 224 employees
46
SEC Filings
$22.38
Close 2026-08-28
224
Employees

Business Summary

Alumis Inc. is a clinical-stage biopharmaceutical company focused on developing targeted therapies for immune-mediated diseases. Its lead asset, envudeucitinib (envu), is an allosteric TYK2 inhibitor in Phase 3 trials for plaque psoriasis and Phase 2 for SLE, with NDA submission planned for 2026. Its pipeline also includes A-005, a CNS-penetrant TYK2 inhibitor, and lonigutamab, a monoclonal antibody targeting IGF-1R for Thyroid Eye Disease, acquired via the ACELYRIN merger.

Latest Stock Quote

ALMS 2026-08-28 $22.38 O:$22.83 H:$23.28 L:$22.35 Vol:0.7M VWAP:$22.4925
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-06

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-192025-12-310001847367-26-000006EDGAR130K words
2025-03-192024-12-310001847367-25-000012EDGAR108K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-132026-06-300001847367-26-000018EDGAR85K words
2025-11-132025-09-300001847367-25-000050EDGAR88K words
2025-08-132025-06-300001847367-25-000041EDGAR88K words
2025-05-142025-03-310001847367-25-000028EDGAR81K words
2024-11-132024-09-300001847367-24-000005EDGAR75K words
2024-08-132024-06-300001558370-24-012081EDGAR77K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-010001104659-26-104145EDGAR4K words
2026-08-130001847367-26-000016EDGAR3K words
2026-08-100001104659-26-093353EDGAR2K words
2026-03-300001104659-26-036386EDGAR4K words
2026-03-190001847367-26-000004EDGAR3K words
2026-01-090001104659-26-002265EDGAR19K words
2026-01-060001104659-26-001073EDGAR4K words
2026-01-020001104659-26-000197EDGAR1K words
2025-11-130001847367-25-000048EDGAR3K words
2025-09-030001104659-25-086612EDGAR6K words

46 total filings indexed. 28 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

immune-mediated-diseases dermatology-(plaque-psoriasis) rheumatology/autoimmunity-(systemic-lupus-erythematosus) neuroinflammation-and-neurodegeneration ophthalmology-(thyroid-eye-disease)

Company Identity

CIK0001847367
TickerALMS
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.alumis.com
Listed2024-06-28

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 6b412414e50866eabef454d5b7aaadc0f2704109eaf33c8f9ee77c1eee932fbf
parent: 6c4f0b1760dcf118c71c01aa9560925c1c79b5a76427e56c8f55a1af9a6d9b0a
content hash: 42643cbbe6f599a36506e96ebba29c460b0712f42ac6d1437f0ab04abb0f288c
signed: 2026-09-29T12:00:16.579Z
sources: 8 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up ALMS using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on ALMS, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/ALMS (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.